Impact of synbindin deficiency on immune checkpoint blocker–induced systemic inflammation and multi-organ damage.
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
12139 Background: Immune-related adverse events (irAEs) are a major safety limitation for the broad application of immune checkpoint blockade (ICB) in oncology, yet their precise molecular mechanisms remain unclear. Synbindin, a tethering-associated protein involved in vesicular trafficking and related processes, plays a key role in immune-cell activation and activation of inflammatory signaling pathways and therefore may represent an important initiator and predictive factor for irAEs. Methods: We generated constitutive whole-body Trappc4 knockout (Trappc4-KO) C57BL/6 mice and administered either anti-PD-1 monotherapy or combined anti-PD-1 plus anti-CTLA-4 immune checkpoint blockade via intraperitoneal injection. Plasma biochemical indices and the extent of organ injury were assessed following treatment. Results: Trappc4-KO mice receiving combined anti-PD-1/anti-CTLA-4 treatment exhibited markedly more severe immune-related toxicity and multi-organ injury than wild-type controls. Biochemically, markers of hepatic injury (AST, ALT) were substantially elevated, indicating liver dysfunction; renal function markers (serum creatinine and blood urea nitrogen) were significantly increased, consistent with kidney injury; and cardiac markers (CK-MB, cTnT, cTnI) were also markedly raised. A similar trend, although less pronounced, was observed following anti-PD-1 monotherapy. Histopathological examination corroborated these findings: H&E sections of affected organs showed prominent focal immune cell infiltration, cellular swelling, and areas of necrosis. Conclusions: These data demonstrate that Trappc4 deficiency significantly exacerbates ICB-induced systemic inflammation and multi-organ damage, suggesting that Synbindin plays a critical protective role in the development of irAEs.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Impact of synbindin deficiency on immune checkpoint blocker–induced systemic inflammation and multi-organ damage.
- Date Crossref
- 01/06/2026
- Éditeur
- American Society of Clinical Oncology (ASCO)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Sun Yat-sen University pays non établi dans la noticeUniversité ou école supérieure
-
Fudan University Zhongshan Hospital pays non établi dans la noticeUniversité ou école supérieure
-
Zhongshan Hospital pays non établi dans la noticeÉtablissement de santé
Sun Yat-sen University, Zhongshan Hospital — Fudan University et Zhongshan Hospital.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.